M30, month 4 of dutasteride and minoxidil Progress Pictures 9/1/2025
A 30-year-old male is using dutasteride, minoxidil, ketoconazole shampoo, and various supplements for hair loss, reporting no sexual side effects but experiencing tinnitus. He stopped microneedling and tretinoin cream, saw quick results, and experiences low-intensity shedding.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity My temples after 2.5 months on oral fin/dut, ketoconazole shampoo, minoxidil, tretinoin and dermarolling
The user shared progress pictures showing improved hair growth at the temples after 2.5 months using oral finasteride/dutasteride, ketoconazole shampoo, minoxidil, tretinoin, and dermarolling. The user reported no side effects from the medications and noted inconsistent microneedling.
community 1 Year on fin/dut + ketoconazole shampoo
The user has been using dutasteride, finasteride, and ketoconazole shampoo for hair loss, recently adding minoxidil and tretinoin, and plans to start microneedling. They advise starting treatments early to maintain hair, as regrowth is more challenging.
community 20yo, dutasteride and minoxidil aren’t working
A 20-year-old reports worsening hair loss despite using dutasteride and minoxidil, and considers a hair transplant. Users suggest continuing treatments, trying microneedling, ketoconazole shampoo, switching to finasteride, or adding tretinoin.
community M30, month 1 of dutasteride and minoxidil
A 30-year-old male is using a regimen of dutasteride, minoxidil, ketoconazole shampoo, tretinoin cream, and microneedling for hair regrowth. He reports no side effects and has noticed visual improvement after one month.
community M30, month 2 of dutasteride and minoxidil
A user shared their two-month progress using dutasteride, minoxidil, ketoconazole shampoo, and tretinoin cream for hair loss, reporting no side effects and increased sex drive. Other users discussed their experiences with similar treatments, including finasteride and oral minoxidil, and debated the effectiveness of microneedling.
Related Research
6 / 6 results
research Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
This review discusses the potential of using SULT1A1 expression in the scalp as a biomarker to predict response to minoxidil treatment for androgenetic alopecia, but reports no new clinical results.
research Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
This review provides a detailed overview of the causes, prevalence, pathophysiology, clinical presentation, and treatment of beard alopecia, highlighting conditions such as alopecia areata, pseudofolliculitis barbae, and tinea barbae, and aims to serve as a resource for clinicians handling such cases.
research Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
This article discusses treatments for female pattern hair loss, highlighting that oral antiandrogens and topical minoxidil can effectively arrest progression and reverse miniaturization in many patients with mild-to-moderate cases, but it reports no new clinical results.
research Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
This guideline review by the European Dermatology Forum evaluates current treatments for androgenetic alopecia but reports no new research findings, aiming to assist dermatologists in selecting safe and effective therapies.
research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
research Minoxidil: a comprehensive review
This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.